Assessing comparative effectiveness research in the US

Business & Economics

• Prescribing 36%
• United States of America 26%
• Reimbursement 23%
• Systematic Review 20%
• Drugs 12%
• Evidence-based Practice 10%
• Clearinghouse 10%
• Filter 7%
• Federal Government 7%
• Pharmaceuticals 6%
• Inference 6%
• Inclusion 6%
• Stakeholders 4%
• Government 4%

Medicine & Life Sciences

• Comparative Effectiveness Research 100%
• Systematic Reviews 10%
• Federal Government 9%
• Pharmaceutical Services 9%
• Evidence-Based Practice 8%
• Pharmaceutical Preparations 6%
• Therapeutics 1%

Social Sciences

• evidence 15%
• drug 10%
• clinical outcomes 9%
• pharmaceutical 6%
• Federal Government 6%
• stimulus 5%
• coverage 5%
• stakeholder 5%
• inclusion 5%
• time 2%